DUPROST (Dutasteride) is a widely prescribed medication used for the treatment of benign prostatic hyperplasia (BPH), a condition commonly known as an enlarged prostate. BPH affects millions of men across the United States, the United Kingdom, and Canada, often leading to urinary difficulties such as frequent urination, weak urine flow, or difficulty starting and stopping urination. By addressing the root hormonal cause of prostate enlargement, DUPROST helps improve urinary function and overall quality of life.
The active ingredient, dutasteride, works by inhibiting the conversion of testosterone into dihydrotestosterone (DHT). Excess DHT is a major contributor to prostate growth, and by lowering its levels, DUPROST reduces prostate size and relieves pressure on the urinary tract. Over time, this helps men experience improved bladder control, reduced urgency, and fewer nighttime trips to the bathroom.
In addition to managing BPH, DUPROST (Dutasteride) may also support long-term prostate health by minimizing the risk of complications that arise from untreated enlargement. It is often chosen as part of a prescribed treatment plan because of its proven safety profile and effectiveness when taken consistently. Many men begin to notice symptom improvement within a few months of use, with full benefits achieved through long-term adherence.
DUPROST is taken orally, usually once daily, making it a convenient and straightforward treatment option. It is important to use this medication only under medical supervision, as your healthcare provider will determine the right dosage and duration of therapy for your needs. While generally well-tolerated, some men may experience mild side effects, and it should not be handled by women who are pregnant or planning pregnancy.
For men in the USA, UK, and Canada seeking an effective solution for benign prostatic hyperplasia, DUPROST (Dutasteride) remains a reliable choice backed by FDA approval and trusted by healthcare professionals worldwide.